Duodenal Ulcer Associated with Exudative Esophagitis in a Patient with Gastrointestinal Bleeding: A Case Report
Úlcera duodenal associada à esofagite exsudativa em paciente com hemorragia digestiva: Relato de caso
DOI:
https://doi.org/10.22258/hgh.v10i3.481Abstract
Peptic ulcer disease remains a major cause of upper gastrointestinal haemorrhage, particularly in patients with risk factors such as chronic alcohol consumption, Helicobacter pylori infection and prolonged use of anti-inflammatory drugs. The aim of this article is to report a clinical case of an unusual clinical association between a duodenal ulcer and exudative oesophagitis, involving multiple risk factors. This is a 52-year-old male patient from a suburban area with a history of chronic epigastric pain associated with alcohol consumption; over the preceding months, his condition had progressed to include melena, bloody diarrhoea, weight loss, odynophagia and black vomit. He was admitted with severe epigastric pain and signs of malnutrition and severe anaemia (Hb 6.9 g/dL). Upper gastrointestinal endoscopy revealed oesophagitis with whitish exudate and a duodenal ulcer at the bulb. Clinical management was initiated with an intravenous proton pump inhibitor, empirical antibiotic therapy in view of the possibility of H. pylori infection, sucralfate and supportive care; the patient’s clinical course was favourable and he was discharged for outpatient follow-up. Duodenal ulcer remains a significant cause of upper gastrointestinal haemorrhage, particularly in patients with associated risk factors. Early endoscopic diagnosis and the prompt initiation of appropriate drug treatment are essential for preventing serious complications and improving the clinical prognosis. Keywords: Peptic Ulcer; Gastrointestinal Hemorrhage; Endoscopy, Gastrointestinal; Anemia; Angola (Source: MeSH, NLM).Downloads
References
Sung JJY, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009;29(9):938-46. DOI:10.1111/j.1365-2036.2009.03960.x.
Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;71(9):1724-62. DOI:10.1136/gutjnl-2022-327745.
Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107(3):345-60; quiz 361. DOI:10.1038/ajg.2011.480.
Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117(1):27-56. DOI:10.14309/ajg.0000000000001538.
Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390(10094):613-24. DOI:10.1016/S0140-6736(16)32404-7.
Peterson WL, Barnett C, Walsh JH. Effect of intragastric infusions of ethanol and wine on serum gastrin concentration and gastric acid secretion. Gastroenterology. 1986;91(6):1390-5. DOI:10.1016/0016-5085(86)90192-7.
Chicaybam KF. Estudo epidemiológico das internações por úlcera gástrica e duodenal no Brasil, entre 2020 e 2024. Braz J Implantol Health Sci. 2025;7(7):1588-1605. DOI:10.36557/2674-8169.2025v7n7p1588-1605.
Gopal P, Gibson JA, Lisovsky M, Nalbantoglu I. Unique causes of esophageal inflammation: a histopathologic perspective. Ann N Y Acad Sci. 2018;1434(1):219-26. DOI:10.1111/nyas.13732.
Mohamed AA, Lu XL, Mounmin FA. Diagnosis and treatment of esophageal candidiasis: current updates. Can J Gastroenterol Hepatol. 2019;2019:3585136. DOI:10.1155/2019/3585136.
Boyd EJS. The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia. Am J Gastroenterol. 1996;91(8):1539-43.
Cotton PB, Shorvon PJ. Analysis of endoscopy and radiography in the diagnosis, follow-up and treatment of peptic ulcer disease. Clin Gastroenterol. 1984;13(2):383-403. DOI:10.1016/S0300-5089(21)00618-0.
Montenegro Sisalema RZ, Sotomayor Haro JD, Acosta Pozo MA, Silva Mena JC, Godoy Hernández JN, Mendieta Vélez EJ, et al. Diagnóstico y manejo de la enfermedad ulcerosa péptica: revisión de literatura. Ibero-Am J Health Sci Res. 2025;5(1):64-73. DOI:10.56183/iberojhr.v5i1.700.
Jorge C, Tuna C, Carlos P, Ferreira S, Gonçalves R, Louro M. Indicações terapêuticas e profiláticas de uso de inibidores da bomba de protões e prescrição inadequada. Med Interna. 2022;29(1):8-12. DOI:10.24950/rspmi.2022.01.192.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Jorge Chiwale Kussecala, João Lando Kanga, Joaquim Augusto Lombe Cassinda, Fernando Alberto Quilezi

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The authors will retain their copyright and will guarantee to the journal right of first publication of their work, which will simultaneously be under a Creative Commons Attribution 4.0 License that allows third parties to share the work whenever attribuying their author and first publication in this journal.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post online a pre-publication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).






